Welcome to LookChem.com Sign In|Join Free
  • or
N-cuban-1-ylmethyl-2-fluoro-benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1030835-63-2

Post Buying Request

1030835-63-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1030835-63-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1030835-63-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,0,8,3 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1030835-63:
(9*1)+(8*0)+(7*3)+(6*0)+(5*8)+(4*3)+(3*5)+(2*6)+(1*3)=112
112 % 10 = 2
So 1030835-63-2 is a valid CAS Registry Number.

1030835-63-2Downstream Products

1030835-63-2Relevant academic research and scientific papers

Cubyl amides: Novel P2X7 receptor antagonists

Gunosewoyo, Hendra,Guo, Jun Liu,Bennett, Maxwell R.,Coster, Mark J.,Kassiou, Michael

supporting information; experimental part, p. 3720 - 3723 (2009/04/06)

Polycyclic amides 2 and 5-9 were successfully synthesised and their lipophilicity profiles were evaluated using reverse-phase HPLC. All synthesised compounds possessed P2X7R antagonistic properties when tested on rat spinal cord microglia cells. Extensive screening for binding to other neuroreceptor subtypes demonstrated their P2X7 selectivity.

POLYCYCLIC MOLECULAR COMPOUNDS

-

Page/Page column 61; 63-64, (2008/12/06)

This invention relates to compounds of Formula (I), wherein A is a carboaromatic or heteroaromatic ring having one or more substituents; R6 Formula (A) is optionally substituted with one or more substituents; and n is 0, 1 or an integer greater than 1 and when n is 1 or greater the bond or bonds between the carbon atoms may be saturated or unsaturated, which bind the P2X7 receptor with high affinity. This invention also relates to methods for the diagnosis, treatment or monitoring of disorders in which the P2X7 receptor is implicated, in particular the diagnosis, treatment or monitoring of (the progression of) neuroinflammatory and neurodegenerative disorders in a subject.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1030835-63-2